Lucid Diagnostics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lucid Diagnostics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2021 to Q3 2024.
  • Lucid Diagnostics Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 30, 2024 was 55.5M shares, a 24.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.5M +10.8M +24.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 53.2M +9.52M +21.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 49M +5.65M +13% Mar 31, 2024 10-Q 2024-05-13
Q3 2023 44.7M +5.56M +14.2% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 43.7M +5.16M +13.4% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 43.4M +5.96M +15.9% Mar 9, 2023 10-K 2023-03-14
Q3 2022 39.1M Nov 10, 2022 10-Q 2022-11-14
Q2 2022 38.6M Aug 10, 2022 10-Q 2022-08-15
Q1 2022 37.4M Mar 29, 2022 10-K 2022-04-06
Q4 2021 36.8M Nov 18, 2021 10-Q 2021-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.